Medical condition
Multiple Sclerosis
Multiple Sclerosis is a medical condition tracked by NovaPharmaNews across 12 associated drugs and ongoing industry coverage. Explore approved and pipeline therapies, regulatory status, and the latest developments.
Associated drugs & therapies
- laquinimod (NERVENTRA) Nervous system (N07)
- teriflunomide (APO-TERIFLUNOMIDE) Antineoplastic and immunomodulating agents (L04)
- ponesimod (PONVORY) Antineoplastic and immunomodulating agents (L04)
- dimethyl fumarate (APO-DIMETHYL FUMARATE) Antineoplastic and immunomodulating agents (L04)
- dextromethorphan hydrobromide (NUEDEXTA) Nervous system (N07)
- azathioprine (APO-AZATHIOPRINE) Antineoplastic and immunomodulating agents (L04)
- fingolimod (AKM FINGOLIMOD) Antineoplastic and immunomodulating agents (L04)
- ofatumumab (KESIMPTA) Antineoplastic and immunomodulating agents (L04)
- alemtuzumab (LEMTRADA) Antineoplastic and immunomodulating agents (L04)
- daclizumab (ZENAPAX) Antineoplastic and immunomodulating agents (L04)
- diroximel fumarate (VUMERITY) Antineoplastic and immunomodulating agents (L04)
- natalizumab (TYSABRI) Antineoplastic and immunomodulating agents (L04)
